We are live on ! Find out more
ONCO icon

Onconetix
ONCO

9 hedge funds and large institutions have $242K invested in Onconetix in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

80% more funds holding

Funds holding: 5 → 9 (+4)

0% less ownership

Funds ownership: 0% → 0% (-0%)

93% less capital invested

Capital invested by funds: $3.23M → $242K (-$2.99M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$132K
2
Millennium Management
Millennium Management
New York
+$91.1K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$20.2K
4
TRCT
Tower Research Capital (TRC)
New York
+$20.2K

Top Sellers

Rank Fund Capital Flow
1
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$840K
2
Bank of America
Bank of America
North Carolina
-$10.1K
3
UBS Group
UBS Group
Switzerland
-$10.1K
4
APC
Aspire Private Capital
North Carolina
-$78

ONCO Hedge Fund Activity: Q4 2024 in Review

9 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q4 2024, worth a combined $242K — down 93% from $3.23M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ONCO positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $132K. The largest seller was Zurich Cantonal Bank, cutting an estimated $840K.

  • 9 institutional investors held Onconetix (ONCO) as of Q4 2024, up from 5 in Q3 2024.
  • Funds reported $242K of Onconetix stock for Q4 2024, down 93% quarter-over-quarter.
  • 5 funds opened new Onconetix positions in Q4 2024 and 1 closed out, a net change of +4 holders.
  • The largest Onconetix buyer in Q4 2024 was Geode Capital Management, an estimated $132K added.
  • The largest Onconetix seller in Q4 2024 was Zurich Cantonal Bank, an estimated $840K sold.

Based on aggregated 13F filings for Q4 2024.